Shanghai RAAS Blood Products Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 1,755.724 million compared to CNY 1,309.311 million a year ago. Operating income was CNY 1,027.090 million compared to CNY 815.300 million a year ago. Net income was CNY 910.429 million compared to CNY 696.718 million a year ago. Basic earnings per share from continuing operations was CNY 0.135 compared to CNY 0.113 a year ago.